Cardiovascular Disease Doctors in Lodi, CA Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Harpreet Singh Parmar, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 999 S Fairmont Ave Ste 130, Lodi, CA 95240 Phone: 209-366-2001

Dr. George D Mitchell, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 319 Cornelia Ave, Lodi, CA 95242 Phone: 805-218-9397    Fax: 805-218-9397

Dr. Elizabeth Ann Hereford, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 999 S Fairmont Ave Ste 220, Lodi, CA 95240 Phone: 209-334-9462    Fax: 209-334-9470

David Joseph Magorien, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 999 S Fairmont Ave, Suite 130, Lodi, CA 95240 Phone: 209-366-2001

Steven Jay Block, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 777 S Ham Ln, Ste G, Lodi, CA 95242 Phone: 209-334-3278    Fax: 209-334-1727

News Archive

'Flexi-Scope' test reduces incidence of bowel cancer

A one-off screening test that takes just five minutes could reduce the risk of bowel cancer by one-third and save thousands of lives, UK scientists have said.

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.

ACR develops 3 new guidance documents, revises 32 others to advance science of radiology

The American College of Radiology developed 3 new guidance documents and revised 32 others to advance the science of radiology and improve the quality of service to patients.

Mylan signs definitive agreement to acquire Famy Care's female health care businesses

Mylan Inc. today announced that it has, through its Indian subsidiary Mylan Laboratories Limited, signed a definitive agreement to acquire certain female health care businesses from Famy Care Limited, a specialty women's health care company with global leadership in generic oral contraceptive products (OCPs) for $750 million in cash plus additional contingent payments of up to $50 million.

Life Technologies revenue for third quarter increases 3% to $936

Life Technologies Corporation (NASDAQ: LIFE) today announced results for its third quarter ended September 30, 2013. Revenue for the third quarter was $936 million, an increase of 3 percent over the $911 million reported for the third quarter of 2012.

Read more Medical News

› Verified 2 days ago